Direct evidence suggests that sorafenib induces autophagy by upregulating the expression of Beclin 1 and modulating Beclin 1 acetylation levels makes HCC cells sensitive to sorafenib66. The gene discussed is BECN1; the disease is hepatocellular carcinoma.